Lilly's phase 2 retatrutide results show the investigational molecule achieved up to 17.5% mean weight reduction
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
For the treatment of Superficial Femoral Artery
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
The only robotic-arm assisted surgical device to conduct joint replacement with accuracy and better clinical outcomes
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
Subscribe To Our Newsletter & Stay Updated